VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism

Nature

Volumn 417, Issue 6892, 2002, Pages 954-958

  Gerber, Hans Peter ^a   Malik, Ajay K ^a   Solar, Gregg P ^a   Sherman, Daniel ^a   Liang, Xiao Huan ^a   Meng, Gloria ^a   Hong, Kyu ^a   Marsters, James C ^a   Ferrara, Napoleone ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABLATION; BIOMIMETIC MATERIALS; BLOOD; ENZYME INHIBITION; GENES; PHYSIOLOGY;

HAEMATOPOIESIS; MICE;

CELLS;

VASCULOTROPIN;

BIOLOGY; GENE; GROWTH;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CELL COMPARTMENTALIZATION; CELL POPULATION; CELL SURVIVAL; CYTOKINE RELEASE; DNA FLANKING REGION; ENDOTHELIUM CELL; GENE DELETION; HEMATOPOIETIC STEM CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALS; AUTOCRINE COMMUNICATION; CELL DIVISION; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; CELLS, CULTURED; CLONE CELLS; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; FLOW CYTOMETRY; GENE DELETION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; LYMPHOKINES; MICE; MICE, KNOCKOUT; PARACRINE COMMUNICATION; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SOLUBILITY; TRANSDUCTION, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTORS;

ANIMALIA;

EID: 0037182861     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature00821     Document Type: Article

References (30)

1. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
2. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
3. Autocrine/paracrine mechanisms in human hematopoiesis
4. Expression and secretion of vascular endothelial growth factor-A by cytokine-stimulated hematopoietic progenitor cells. Possible role in the hematopoietic microenvironment
5. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
6. Flk-1 expression defines a population of early embryonic hematopoietic precursors
7. Deficient T cell fare specification in mice with an induced inactivation of Notch1
8. VEGF is required for growth and survival in neonatal mice
9. Role of c-mp1 in early hematopoiesis
10. A role for the Wnt gene family in hematopoiesis: Expansion of multilineage progenitor cells
11. Mechanism of autocrine stimulation in hematopoietic cells producing interleukin-3 after retrovirus-mediated gene transfer
12. Expression of a hemapoietic growth factor cDNA in a factor-dependent cell line results in autonomous growth and tumorigenicity
13. ZD4190: An orally active inhibitor of vascular endothelial growth factor signalling with broad-spectrum antitumor efficacy
14. Design, synthesis, and evaluations of substituted 3-[(3- or 4-carboxyethylpyrrol-2-yl)methylidenyl]indolin-2-ones as inhibitors of VEGF, FGF, and PDGF receptor tyrosine kinases
15. Analysis of biological effects and signalling properties of Flt-1 and KDR: A reassessment using novel highly receptor-specific VEGF mutants
16. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR
17. Vascular permeability factor (VPF)/vascular endothelial growth factor (VEGF) receptor-1 down-modulates VPF/VEGF receptor-2-mediated endothelial cell proliferation, but not migration, through phosphatidylinositol 3-kinase-dependent pathways
18. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1
19. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumour angiogenesis and growth
20. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation
21. Cytokine and chemokine production by CD34 + haemopoietic progenitor cells: Detection in single cells
22. Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes
23. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia
24. Inhibition of both paracrine and autocrine VEGF/VEGFR-2 signalling pathways is essential to induce long-term remission of xenotransplanted human leukemias
25. Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension
26. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema
27. Preclinical safety evaluation of rhuMAbVEGF, an antiangiogenic humanized monoclonal antibody
28. Complete inhibition of rhabdomyosarcoma xenograft growth and neovascularization requires blockade of both tumour and host vascular endothelial growth factor
29. Design and structure-activity relationship of a new class of potent VEGF receptor tyrosine kinase inhibitors
30. The antiangiogenic protein kinase inhibitors SU5416 and SU6668 inhibit the SCF receptor (c-kit) in a human myeloid leukemia cell line and in acute myeloid leukemia blasts